Nov 04 (Reuters) - NeuroPace, Inc. Q3 revenue USD 27.354 million vs. IBES estimate USD 24.6 million.
Q3 gross profit USD 21.168 million
Q3 net income USD -3.496 million
Q3 income from operations USD -2.6 million
Q3 operating expenses USD 23.768 million
outlook FY revenue USD 97-98 million
outlook FY gross margin 76-77%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.